CLINICAL_TRIALS
trial_result
· 2010-12-02
Clinical Trial Update: Etanercept (Enbrel) for Juvenile Myelomonocytic Leukemia [Phase 2]
Summary
A Phase 2 trial of etanercept (Enbrel) for Juvenile myelomonocytic leukemia was terminated. Results were posted in 2010.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: M.D. Anderson Cancer Center | Conditions: Leukemia | Phase 2 | Status: TERMINATED | Results posted: 2010-12-02